Oric Pharmaceuticals Stock Price on March 6, 2024
| ORIC Stock | USD 9.90 0.07 0.70% |
Below is the normalized historical share price chart for Oric Pharmaceuticals extending back to April 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oric Pharmaceuticals stands at 9.90, as last reported on the 30th of November, with the highest price reaching 10.07 and the lowest price hitting 9.78 during the day.
If you're considering investing in Oric Stock, it is important to understand the factors that can impact its price. At this point, Oric Pharmaceuticals is somewhat reliable. Oric Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0123, which implies the firm had a 0.0123% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Oric Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Oric Pharmaceuticals' Risk Adjusted Performance of 0.0142, semi deviation of 4.34, and Coefficient Of Variation of 12239.39 to confirm if the risk estimate we provide is consistent with the expected return of 0.0471%.
As of November 30, 2024, Common Stock is expected to decline to 3,614. In addition to that, Total Stockholder Equity is expected to decline to about 189.3 M. As of November 30, 2024, Price Earnings Ratio is expected to decline to -4.94. In addition to that, Price Book Value Ratio is expected to decline to 2.01. Oric Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of April 2020 | 200 Day MA 10.0385 | 50 Day MA 9.5916 | Beta 1.122 |
Oric |
Sharpe Ratio = 0.0123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ORIC |
Estimated Market Risk
| 3.84 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oric Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oric Pharmaceuticals by adding Oric Pharmaceuticals to a well-diversified portfolio.
Price Book 2.5497 | Book Value 3.883 | Enterprise Value 429.4 M | Enterprise Value Ebitda 0.1311 | Shares Float 42.7 M |
Related Headline
Enliven Therapeutics Headline on 6th of March 2024
Filed transaction by Enliven Therapeutics Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Oric Pharmaceuticals Valuation on March 6, 2024
It is possible to determine the worth of Oric Pharmaceuticals on a given historical date. On March 6, 2024 Oric was worth 15.71 at the beginning of the trading date compared to the closed value of 16.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oric Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Oric Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oric Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oric Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 14.91 | 15.75 | 14.56 | 15.49 | 611,629 | |
03/06/2024 | 15.71 | 16.65 | 15.49 | 16.03 | 622,394 |
| 16.13 | 16.36 | 15.75 | 15.91 | 294,010 |
| Backtest Oric Pharmaceuticals | | | Oric Pharmaceuticals History | | | Oric Pharmaceuticals Valuation | Previous | Next |
Oric Pharmaceuticals Trading Date Momentum on March 6, 2024
| On March 07 2024 Oric Pharmaceuticals was traded for 15.91 at the closing time. The top price for the day was 16.36 and the lowest listed price was 15.75 . The trading volume for the day was 294 K. The trading history from March 7, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.75% . The trading delta at closing time against the current closing price is 5.18% . |
Oric Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Oric Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oric Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oric financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oric Pharmaceuticals Stock history
Oric Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oric is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oric Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oric Pharmaceuticals stock prices may prove useful in developing a viable investing in Oric Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.5 M | 36.7 M | |
| Net Loss | -80.2 M | -84.2 M |
Oric Pharmaceuticals Quarterly Net Working Capital |
|
Oric Pharmaceuticals Stock Technical Analysis
Oric Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oric Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Oric Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oric Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Oric Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oric Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oric Pharmaceuticals stock market strength indicators, traders can identify Oric Pharmaceuticals entry and exit signals to maximize returns
Oric Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oric Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Oric Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oric to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0142 | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0111 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |